Related Experiment Video
Updated: Jul 9, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Restless legs syndrome: an update on genetics and future perspectives
I Pichler1, A A Hicks, P P Pramstaller
1Institute of Genetic Medicine, European Academy, Bolzano, Italy.
Clinical Genetics
|December 12, 2007
Summary
Restless Legs Syndrome (RLS) is a common neurological disorder with genetic links. Recent studies identify new genetic associations, highlighting the condition's complex genetic heterogeneity.
Area of Science:
- Neurology
- Genetics
- Epidemiology
Background:
- Restless Legs Syndrome (RLS) is a prevalent neurological disorder, often underdiagnosed, affecting up to 14% of the population.
- Familial aggregation of RLS has been recognized since 1945, suggesting a strong genetic component.
- Previous genetic research identified several loci but lacked specific gene associations.
Purpose of the Study:
- To review the clinical characteristics, diagnosis, and epidemiology of RLS.
- To focus on the genetic underpinnings and pathogenesis of Restless Legs Syndrome.
- To synthesize current knowledge on genetic heterogeneity in RLS.
Main Methods:
- Review of existing literature on RLS clinical features and epidemiology.
- Analysis of reported genetic loci and genome-wide association studies (GWAS).
- Examination of molecular findings and phenotype variability.
Main Results:
- Two recent GWAS identified significant associations with sequence variants near genes on chromosomes 6p, 2p, and 15q.
- Despite identified loci, specific gene associations within these regions and other candidates remain largely unreported.
- The study highlights substantial clinical and genetic heterogeneity in RLS.
Conclusions:
- RLS exhibits significant genetic heterogeneity, supported by molecular findings and variable expressivity.
- Further research is needed to identify specific genes and understand their role in RLS pathogenesis.
- Comprehensive review underscores the complexity of RLS genetics and the need for continued investigation.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...